Agency Links:    Home   Contact Us    Compliments & Complaints   Help    Site Map
Link to Homepage

Patient/Public Info  |  Regional Services  |  Health Professionals Info  |  About BCCA  |  Research  |  Donating

Neuro-Oncology

The information contained in these documents is a statement of consensus of BC Cancer Agency professionals regarding their views of currently accepted approaches to treatment. Any clinician seeking to apply or consult these documents is expected to use independent medical judgement in the context of individual clinical circumstances to determine any patient's care or treatment. Use of these documents is at your own risk and is subject to BC Cancer Agency's terms of use available at www.bccancer.bc.ca/legal.htm .

  • Glioma (adjuvant) 
  • Glioma (advanced) 
  • Primary Neuroectomdermal Tumours (PNET)
  • Pituitary
  • PLEASE NOTE: All links in the table below open PDF documents .(See Regional Preprinted Orders for Inpt)

    Glioma, Adjuvant: AVAILABLE DOCUMENTS
    (revision date indicated in red)
    CNAJTZRT: Concomitant and Adjuvant Temozolomide for Newly Diagnosed Malignant Gliomas.  - Protocol (01 Dec 2010)
     - Preprinted order (01 Dec 2010)
     - Patient Handout
    (01 Dec 2010)
     
    Glioma, Advanced: AVAILABLE DOCUMENTS
    (revision date indicated in red)
    UCNBEV: Palliative Therapy for Recurrent Malignant Gliomas Using Bevacizumab.  - Protocol (01 Oct 2011)
     - Preprinted order (01 Apr 2012) 
     - Patient Handout
    (01 Apr 2011)
    CNCARV: Carboplatin and Etoposide in the Treatment of Recurrent Ependymoma.  - Protocol (29 Jun 2011)
     -
    Preprinted order (29 Jun 2011)
    CNCCNU: Lomustine (CCNU) for Treatment of Recurrent Malignant Brain Tumors.  - Protocol (04 Jul 2011)
     -
    Preprinted order (01 May 2009)
    CNETO: Palliative treatment of patients with recurrent malignant gliomas and ependymoma using low dose etoposide.  - Protocol (01 May 2009)
     - Preprinted order 
    (01 Sep 2009)
    CNMODPCV: Modified PCV Chemotherapy Of Brain Tumours Using Procarbazine, Lomustine (CCNU) and Vincristine.  - Protocol (29 Jun 2011)
     - Preprinted order (29 Jun 2011)
    CNPROC: Standard Procarbazine for second-line treatment of recurrent brain tumor.  - Protocol (01 May 2009)
     -
    Preprinted order (01 May 2009)
    CNTAM: Tamoxifen for patients with recurrent brain tumors which are resistant to first line chemotherapy.  - Protocol (01 May 2009)
     - 
    Preprinted order (01 May 2009)
    CNTAMCAR: Second and Third Line Treatment of Recurrent Gliomas with Carboplatin and High Dose Tamoxifen  - Protocol (01 May 2009)
     - 
    Preprinted order (29 Jun 2011)
    CNTEMOZ: Therapy for Malignant Brain Tumours using Temozolomide.  - Protocol (01 Aug 2009)
     - Preprinted order 
    (22 Dec 2009)
     
    Patient Handout
    (1 Sep 2009)
    UCNTEMOZMD: Therapy for Malignant Brain Tumours Using Metronomic Dosing of Temozolomide  - Protocol (01 Feb 2012)
     - 
    Preprinted order (1 Mar 2010)
    Primary Neuroectodermal Tumours (PNET): AVAILABLE DOCUMENTS
    (revision date indicated in red)
    CNCCV: Adjuvant lomustine, cisplatin and vincristine in adult high-risk medulloblastoma or other primitive neuroectodermal tumour.  - Protocol (22 Feb 2012)
    - See Regional Preprinted Orders for Inpt
    CNIME: Ifosfamide, mesna and etoposide in the treatment of recurrent brain tumours. Protocol (22 Feb 2012)
    - See Regional Preprinted Orders for Inpt
    CNMODPCV: Modified PCV Chemotherapy Of Brain Tumours Using Procarbazine, Lomustine (CCNU) and Vincristine. See Glioma, Advanced
    Pituitary: AVAILABLE DOCUMENTS
    (revision date indicated in red)
    CNB: Therapy for Prolactinomas using Bromocriptine.  - Protocol (01 May 2009)
     -  Preprinted order
    (01 Dec 2009)
    CNCAB: Second Line Suppressive Therapy for Prolactinomas using Cabergoline.  - Protocol (01 May 2009)
     - Preprinted order (01 Dec 2009)
    CNOCTLAR: Treatment of Growth Hormone Secreting Pituitary Adenoma Using Octreotide. - Protocol (01 Feb 2012)
    -  Preprinted order (01 Feb 2012)
    CNQUIN: Second Line Suppressive Therapy for Prolactinomas using Quinagolide  - Protocol (01 Dec 2009)
     - Preprinted order (01 Dec 2009)